Showing 1–7 of 7 results for author: Iftekhar, E

Impact of the Euro 2020 championship on the spread of COVID-19

Authors: Jonas Dehning, Sebastian B. Mohr, Sebastian Contreras, Philipp Dönges, Emil N. Iftekhar, Oliver Schulz, Philip Bechtle, Viola Priesemann

Abstract: Large-scale events like the UEFA Euro~2020 football (soccer) championship offer a unique opportunity to quantify the impact of gatherings on the spread of COVID-19, as the number and dates of matches played by participating countries resembles a randomized study. Using Bayesian modeling and the gender imbalance in COVID-19 data, we attribute 840,000 (95% CI: [0.39M, 1.26M]) COVID-19 cases across 1… ▽ More Large-scale events like the UEFA Euro~2020 football (soccer) championship offer a unique opportunity to quantify the impact of gatherings on the spread of COVID-19, as the number and dates of matches played by participating countries resembles a randomized study. Using Bayesian modeling and the gender imbalance in COVID-19 data, we attribute 840,000 (95% CI: [0.39M, 1.26M]) COVID-19 cases across 12 countries to the championship. The impact depends non-linearly on the initial incidence, the reproduction number $R$, and the number of matches played. The strongest effects are seen in Scotland and England, where as much as 10,000 primary cases per million inhabitants occur from championship-related gatherings. The average match-induced increase in $R$ was 0.46 [0.18, 0.75] on match days, but important matches caused an increase as large as +3. Altogether, our results provide quantitative insights that help judge and mitigate the impact of large-scale events on pandemic spread. △ Less

Submitted 18 January, 2023; originally announced January 2023.

Comments: 69 pages, 52 figures

Journal ref: Nature Communications 14, 122 (2023)

Interplay between risk perception, behaviour, and COVID-19 spread

Authors: Philipp Dönges, Joel Wagner, Sebastian Contreras, Emil Iftekhar, Simon Bauer, Sebastian B. Mohr, Jonas Dehning, André Calero Valdez, Mirjam Kretzschmar, Michael Mäs, Kai Nagel, Viola Priesemann

Abstract: Pharmaceutical and non-pharmaceutical interventions (NPIs) have been crucial for controlling COVID-19. They are complemented by voluntary health-protective behaviour, building a complex interplay between risk perception, behaviour, and disease spread. We studied how voluntary health-protective behaviour and vaccination willingness impact the long-term dynamics. We analysed how different levels of… ▽ More Pharmaceutical and non-pharmaceutical interventions (NPIs) have been crucial for controlling COVID-19. They are complemented by voluntary health-protective behaviour, building a complex interplay between risk perception, behaviour, and disease spread. We studied how voluntary health-protective behaviour and vaccination willingness impact the long-term dynamics. We analysed how different levels of mandatory NPIs determine how individuals use their leeway for voluntary actions. If mandatory NPIs are too weak, COVID-19 incidence will surge, implying high morbidity and mortality before individuals react; if they are too strong, one expects a rebound wave once restrictions are lifted, challenging the transition to endemicity. Conversely, moderate mandatory NPIs give individuals time and room to adapt their level of caution, mitigating disease spread effectively. When complemented with high vaccination rates, this also offers a robust way to limit the impacts of the Omicron variant of concern. Altogether, our work highlights the importance of appropriate mandatory NPIs to maximise the impact of individual voluntary actions in pandemic control. △ Less

Submitted 11 March, 2022; v1 submitted 22 December, 2021; originally announced December 2021.

Comments: Final version after peer-review (version of record)

Journal ref: Front. Phys. 10 (2022):842180

Nachhaltige Strategien gegen die COVID-19-Pandemie in Deutschland im Winter 2021/2022

Authors: Viola Priesemann, Eberhard Bodenschatz, Sandra Ciesek, Eva Grill, Emil N. Iftekhar, Christian Karagiannidis, André Karch, Mirjam Kretzschmar, Berit Lange, Sebastian A. Müller, Kai Nagel, Armin Nassehi, Mathias W. Pletz, Barbara Prainsack, Ulrike Protzer, Leif Erik Sander, Andreas Schuppert, Anita Schöbel, Klaus Überla, Carsten Watzl, Hajo Zeeb

Abstract: In this position paper, a large group of interdisciplinary experts outlines response strategies against the spread of SARS-CoV-2 in the winter of 2021/2022 in Germany. We review the current state of the COVID-19 pandemic, from incidence and vaccination efficacy to hospital capacity. Building on this situation assessment, we illustrate various possible scenarios for the winter, and detail the mecha… ▽ More In this position paper, a large group of interdisciplinary experts outlines response strategies against the spread of SARS-CoV-2 in the winter of 2021/2022 in Germany. We review the current state of the COVID-19 pandemic, from incidence and vaccination efficacy to hospital capacity. Building on this situation assessment, we illustrate various possible scenarios for the winter, and detail the mechanisms and effectiveness of the non-pharmaceutical interventions, vaccination, and booster. With this assessment, we want to provide orientation for decision makers about the progress and mitigation of COVID-19. △ Less

Submitted 10 November, 2021; originally announced November 2021.

Comments: in German, Extensive expert assessment on COVID-19 response policies for the winter 2021/22

The winter dilemma

Authors: Sebastian Contreras, Philipp Dönges, Joel Wagner, Simon Bauer, Sebastian B. Mohr, Emil N. Iftekhar, Mirjam Kretzschmar, Michael Maes, Kai Nagel, André Calero Valdez, Viola Priesemann

Abstract: With winter coming in the northern hemisphere, disadvantageous seasonality of SARS-CoV-2 requires high immunity levels in the population or increasing non-pharmaceutical interventions (NPIs), compared to summer. Otherwise intensive care units (ICUs) might fill up. However, compliance with mandatory NPIs, vaccine uptake, and individual protective measures depend on individuals' opinions and behavio… ▽ More With winter coming in the northern hemisphere, disadvantageous seasonality of SARS-CoV-2 requires high immunity levels in the population or increasing non-pharmaceutical interventions (NPIs), compared to summer. Otherwise intensive care units (ICUs) might fill up. However, compliance with mandatory NPIs, vaccine uptake, and individual protective measures depend on individuals' opinions and behavior. Opinions, in turn, depend on information, e.g., about vaccine safety or current infection levels. Therefore, understanding how information about the pandemic affects its spread through the modulation of voluntary protection-seeking behaviors is crucial for better preparedness this winter and for future crises. △ Less

Submitted 15 October, 2021; v1 submitted 4 October, 2021; originally announced October 2021.

Comments: Estimation of COVID-19 case numbers for the coming winter

Mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants

Authors: Karen Y. Oróstica, Sebastian Contreras, Sebastian B. Mohr, Jonas Dehning, Simon Bauer, David Medina-Ortiz, Emil N. Iftekhar, Karen Mujica, Paulo C. Covarrubias, Soledad Ulloa, Andrés E. Castillo, Ricardo A. Verdugo, Jorge Fernández, Álvaro Olivera-Nappa, Viola Priesemann

Abstract: The emergence of SARS-CoV-2 variants of concern endangers the long-term control of COVID-19, especially in countries with limited genomic surveillance. In this work, we explored genomic drivers of contagion in Chile. We sequenced 3443 SARS-CoV-2 genomes collected between January and July 2021, where the Gamma (P.1), Lambda (C.37), Alpha (B.1.1.7), B.1.1.348, and B.1.1 lineages were predominant. Us… ▽ More The emergence of SARS-CoV-2 variants of concern endangers the long-term control of COVID-19, especially in countries with limited genomic surveillance. In this work, we explored genomic drivers of contagion in Chile. We sequenced 3443 SARS-CoV-2 genomes collected between January and July 2021, where the Gamma (P.1), Lambda (C.37), Alpha (B.1.1.7), B.1.1.348, and B.1.1 lineages were predominant. Using a Bayesian model tailored for limited genomic surveillance, we found that Lambda and Gamma variants' reproduction numbers were about 5% and 16% larger than Alpha's, respectively. We observed an overabundance of mutations in the Spike gene, strongly correlated with the variant's transmissibility. Furthermore, the variants' mutational signatures featured a breakpoint concurrent with the beginning of vaccination (mostly CoronaVac, an inactivated virus vaccine), indicating an additional putative selective pressure. Thus, our work provides a reliable method for quantifying novel variants' transmissibility under subsampling (as newly-reported Delta, B.1.617.2) and highlights the importance of continuous genomic surveillance. △ Less

Submitted 23 August, 2021; originally announced August 2021.

A look into the future of the COVID-19 pandemic in Europe: an expert consultation

Authors: Emil Nafis Iftekhar, Viola Priesemann, Rudi Balling, Simon Bauer, Philippe Beutels, André Calero Valdez, Sarah Cuschieri, Thomas Czypionka, Uga Dumpis, Enrico Glaab, Eva Grill, Claudia Hanson, Pirta Hotulainen, Peter Klimek, Mirjam Kretzschmar, Tyll Krüger, Jenny Krutzinna, Nicola Low, Helena Machado, Carlos Martins, Martin McKee, Sebastian Bernd Mohr, Armin Nassehi, Matjaž Perc, Elena Petelos , et al. (9 additional authors not shown)

Abstract: How will the coronavirus disease 2019 (COVID-19) pandemic develop in the coming months and years? Based on an expert survey, we examine key aspects that are likely to influence COVID-19 in Europe. The future challenges and developments will strongly depend on the progress of national and global vaccination programs, the emergence and spread of variants of concern, and public responses to nonpharma… ▽ More How will the coronavirus disease 2019 (COVID-19) pandemic develop in the coming months and years? Based on an expert survey, we examine key aspects that are likely to influence COVID-19 in Europe. The future challenges and developments will strongly depend on the progress of national and global vaccination programs, the emergence and spread of variants of concern, and public responses to nonpharmaceutical interventions (NPIs). In the short term, many people are still unvaccinated, VOCs continue to emerge and spread, and mobility and population mixing is expected to increase over the summer. Therefore, policies that lift restrictions too much and too early risk another damaging wave. This challenge remains despite the reduced opportunities for transmission due to vaccination progress and reduced indoor mixing in the summer. In autumn 2021, increased indoor activity might accelerate the spread again, but a necessary reintroduction of NPIs might be too slow. The incidence may strongly rise again, possibly filling intensive care units, if vaccination levels are not high enough. A moderate, adaptive level of NPIs will thus remain necessary. These epidemiological aspects are put into perspective with the economic, social, and health-related consequences and thereby provide a holistic perspective on the future of COVID-19. △ Less

Submitted 23 July, 2021; v1 submitted 4 July, 2021; originally announced July 2021.

Comments: Manuscript is accepted by The Lancet Regional Health - Europe as a Viewpoint article. Supplementary material can be accessed here: https://owncloud.gwdg.de/index.php/f/1439962756

Journal ref: Lancet Reg. Health Eur. 8, 100185 (2021)

Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves

Authors: Simon Bauer, Sebastian Contreras, Jonas Dehning, Matthias Linden, Emil Iftekhar, Sebastian B. Mohr, Álvaro Olivera-Nappa, Viola Priesemann

Abstract: Mass vaccination offers a promising exit strategy for the COVID-19 pandemic. However, as vaccination progresses, demands to lift restrictions increase, despite most of the population remaining susceptible. Using our age-stratified SEIRD-ICU compartmental model and curated epidemiological and vaccination data, we quantified the rate (relative to vaccination progress) at which countries can lift non… ▽ More Mass vaccination offers a promising exit strategy for the COVID-19 pandemic. However, as vaccination progresses, demands to lift restrictions increase, despite most of the population remaining susceptible. Using our age-stratified SEIRD-ICU compartmental model and curated epidemiological and vaccination data, we quantified the rate (relative to vaccination progress) at which countries can lift non-pharmaceutical interventions without overwhelming their healthcare systems. We analyzed scenarios ranging from immediately lifting restrictions (accepting high mortality and morbidity) to reducing case numbers to a level where test-trace-and-isolate (TTI) programs efficiently compensate for local spreading events. In general, the age-dependent vaccination roll-out implies a transient decrease of more than ten years in the average age of ICU patients and deceased. The pace of vaccination determines the speed of lifting restrictions; Taking the European Union (EU) as an example case, all considered scenarios allow for steadily increasing contacts starting in May 2021 and relaxing most restrictions by autumn 2021. Throughout summer 2021, only mild contact restrictions will remain necessary. However, only high vaccine uptake can prevent further severe waves. Across EU countries, seroprevalence impacts the long-term success of vaccination campaigns more strongly than age demographics. In addition, we highlight the need for preventive measures to reduce contagion in school settings throughout the year 2021, where children might be drivers of contagion because of them remaining susceptible... △ Less

Submitted 15 July, 2021; v1 submitted 10 March, 2021; originally announced March 2021.

Journal ref: PLoS Comput Biol 17(9): e1009288 (2021)